Find your path to Rami
560 people in our graph share verified history with Rami — schools, employers, funds. One of them is your warm intro.
Dan LynchunlockedRami: together at Blueprint Medicines (2013–2018)
×2Rami: together at MIT
Rami: together at Harvard Medical School
×8Rami: together at MPM BioImpact
About
Partner responsible for investment identification and due diligence of public equities. Spent majority of career in drug discovery for precision oncology and immunotherapy, most recently as Senior Director of Cancer Biology at Scorpion Therapeutics. Ph.D. from MIT in Genetics.
Experience
- MPM BioImpactPartnercurrent2025 — presentBoston, Massachusetts, United States
- MPM BioImpactSenior Principal2024 — 2025
- MPM BioImpactPrincipal2022 — 2024
- Scorpion TherapeuticsSenior Director2021 — 2022
- Scorpion TherapeuticsDirector2020 — 2022
- KSQ Therapeutics, Inc.Associate Director2018 — 2020
- Blueprint MedicinesSenior Scientist2015 — 2018Cambridge, MA
- Blueprint MedicinesScientist2013 — 2015Cambridge, MA
- Novartis Institutes of Biomedical ResearchPresidential Fellow2010 — 2013
- Harvard Medical SchoolPostdoctoral fellow2008 — 2010
- MITGraduate Student2003 — 2008Cambridge, MA
Skills & more
Due DiligenceInvestmentsResearch and Development (R&D)Biotechnology IndustryGenomicsOncologyCell BiologyGeneticsBiomarkersSignal TransductionDrug DiscoveryCancer Research
+8 more
DNA sequencingCancer ImmunotherapyBiochemistryMolecular BiologyHigh Throughput ScreeningCell CultureProtein ExpressionAssay DevelopmentLanguages Arabic
From Rami's professional profile.
Colleagues at MPM BioImpact
Alan Kelly
Director at MPM BioImpact
Andrew Scharenberg
Entrepreneur Partner at MPM BioImpact
Ansbert Gadicke, M.D.
Chairman at MPM BioImpact
Ansbert K. Gadicke
Managing Partner at MPM BioImpact
Aparna Parikh
Entrepreneur Partner at MPM BioImpact
Bard Geesaman
Managing Partner at MPM Capital
Binsen Li
Principal at MPM BioImpact
Brendan Furey
Chief Compliance Officer at MPM BioImpact
Frequently asked questions
- Who is Rami Rahal?
- Partner responsible for investment identification and due diligence of public equities. Spent majority of career in drug discovery for precision oncology and immunotherapy, most recently as Senior Director of Cancer Biology at Scorpion Therapeutics. Ph.D. from MIT in Genetics.
- Where does Rami Rahal work?
- Rami Rahal is Partner at MPM BioImpact.
- Where did Rami Rahal go to school?
- Rami Rahal studied at Massachusetts Institute of Technology (PhD, Genetics); McMaster University (Bachelor of Science, Biochemistry).
Same school
Also attended Massachusetts Institute of Technology2,000
Hemant TanejaCEO & Managing Director of General CatalystNat FriedmanCo-lead of Meta Superintelligence Labs; co-founder of NFDGBrad FeldCo-founder of Foundry and TechstarsMatt HuangCo-founder and Managing Partner at ParadigmDelian AsparouhovPartner at Founders Fund and co-founder of VardaDrew HoustonCo-founder & CEO of Dropbox
+ 1,994 more
Also attended McMaster University192
Alex NardiInvestment Manager - Energy at Emerald Technology Ventures AgMark HatfieldInvestor at Ten ElevenEricInvestment Analyst at UpHonest CapitalJulia ZhouPresident and Co-Founder at CaladanPaige DickieVice-President at Radical VenturesKarim LakhaniInvestor at Blue Tulip Ventures
+ 186 more
Shared employers
Also worked at MPM BioImpact51
Christiana BardonManaging Partner of MPM BioImpact, leading the firm's public market investingDetlev BiniszkiewiczManaging Director at MPM BioImpactGisella de la RochaVice President of Legal at MPM BioImpactChristian DesmarteauxDirector of Investor Relations at MPM BioImpactLuke EvninAdvisor at MPM BioImpactTodd FoleyManaging Director at MPM BioImpact
+ 45 more
Also worked at KSQ Therapeutics, Inc.3
Also worked at Blueprint Medicines11
Dan LynchInvestor at GV (Google Ventures)Carlos Garcia-EcheverriaVenture Partner at Ysios CapitalDeborah PalestrantPartner, Executive Chair, 4:59 Initiative at 5AM VenturesAlexis BorisyOperating Chairman at Curie.BioChristoph LengauerCSO at Curie.BioAndy GarnerSenior Vice President at Curie.Bio
+ 5 more
Also worked at Novartis Institutes of Biomedical Research332
Rebecca JamesInvestor at Index VenturesScott BillerInvestor at GV (Google Ventures)Freya Svedberg-KeatingInvestor at MedicxiAndrea AmadorCompliance Manager at Inveready Technology Investment GroupAbbie CelnikerInvestor at Third Rock VenturesJesper GromadaInvestor at Third Rock Ventures
+ 326 more